AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2023
Mar 18, 2023
30583_dirs_2023-03-17_bc9e8c2c-6628-44b1-9434-7971d576396b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2023-03-15
Reporting Person: Guyer Charles Greg (EVP, Chief Technical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-03-15 | Common Stock | A | 8900 | — | Acquired | 51320 | Direct |
| 2023-03-15 | Common Stock | F | 1856 | $87.74 | Disposed | 49464 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-03-15 | Stock Option (Right to buy Common Stock) | $87.74 | A | 20320 | Acquired | 2033-03-14 | Common Stock (20320) | Direct |
Footnotes
F1: Restricted stock units granted on March 15, 2023. Price not applicable.
F2: Option grant vests 12/48th on March 15, 2024 and 1/48th on the 15th day of each month thereafter.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19